EleCare

EleCare

EleCare , by Similac, is the first amino acid-based infant Food for Special Medical Purposes (iFSMP) in the UK containing synthesised 2’-FL*. EleCare has been specially formulated for the management of infants with moderate to severe cow’s milk allergy (CMA), multiple food allergies, and/or those requiring an elemental diet.

Breast milk is the gold standard providing not only nutrition, but protection and support for the developing immune system,^1-3 which is critical, particularly in the first year of life.⁴ However, not every infant with allergies can be breastfed and a number of families depend on hypoallergenic formula.

HMOs are a diverse group of bioactive, non-digestible carbohydrates and the third most abundant solid component of breast milk.^5,6 Breast milk contains many distinct HMOs, which have a positive effect on gut microbiota and play an important role systemically in supporting the developing immune system.^5-8

Following >18 years of extensive research into HMOs, Abbott has found that 2’-FL* is the most abundant HMO in mother’s milk, and we are delighted to be the first and only manufacturer in the UK to add 2’-FL* to an amino acid-based formula.

With EleCare you can:

• Help support the immune needs of infants with CMA in the gut and beyond^**9-11
• While providing the efficacy you expect and need^†12-14
• With a formula that is trusted by mums and healthcare professionals.^15,16

EleCare is provided in a 400g tin.

Register for samples to be delivered directly to your patient by visiting Abbott Samples.

Breastfeeding is best for infants and is recommended for as long as possible during infancy. EleCare is an infant formula for special medical purposes and should be used under the supervision of a healthcare professional.

References:

• 1. Kainonen E, et al. Immunological programming by breast milk creates an anti-inflammatory cytokine milieu in breast-fed infants compared to formula-fed infants. Brit J Nutrition 2013;109(11):1962–1970. 2. Walker A. Breast milk as the gold standard for protective nutrients. J Pediatr 2010;156(Suppl 2):S3–S7. 3. Lessen R, Kavanagh K. Position of the academy of nutrition and dietetics: promoting and supporting breastfeeding. J Acad Nutr Diet 2015;115(3):444–449. 4. . Simon AK, et al. Proc Biol Sci 2015;282(1821): 20143085. 5. Triantis V, et al. Immunological Effects of Human Milk Oligosaccharides. Front Pediatr 2018;6:190. 6. Castanys-Munoz E, et al. Building a Beneficial Microbiome from Birth. Adv Nutr 2016;7(2):323–330. 7. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology 2012;22(9):1147–1162. 8. Stepans MB, et al. Early consumption of human milk oligosaccharides is inversely related to subsequent risk of respiratory and enteric disease in infants. Breastfeed Med 2006;1(4):207–215. 9. . Marriage BJ, et al. J Pediatr Gastroenterol Nutr. 2015;61(6):649–658. 10. Reverri EJ, et al. Nutrients. 2018;10(10). pii: E1346. 11. Goehring KC, et al. J Nutr. 2016;146(12):2559–2566. 12. . Borschel MW, et al. Clin Pediatr (Phila). 2013;52(10):910–917. 13. Borschel MW, et al. BMC Pediatr. 2014;14:136. 14. . Borschel MW, et al. SAGE Open Med. 2014;2:2050312114551857. 15. Abbott. Abbott Insights Hub: Findings from the project ‘EleCare & EleCare Jr No.1 Recommended’. 2018. 16. Abbott. EleCare Promotional Claims Parent Survey. 2019.
• 
  
  

*2’-FL: The 2’-fucosyllactose used in this formula is biosynthesised and structurally identical to the human milk oligosaccharide (HMO) found in most mothers’ breast milk.

**Data collected from healthy-term infants fed standard infant formula (Similac) with 2’-FL*, compared to control formula without 2’-FL*.

†Data collected from infants fed standard EleCare formula without 2’-FL*.